In this oocyte donation setting, we demonstrated that SO (Severe oligozoospermia) is unlikely to significantly affect IVF outcomes following blastocyst development, which contradicts previous findings in less controlled settings
174
Male factor infertility in the setting of oocyte donation is not an indication per se to perform PGT-A.
175
The severe oligozoospermia (SO) group had significantly lower sperm motility and significantly reduced fertilization rates compared to the MO and control groups
176
There was no statistical difference was observed for the blastocyst formation rate (per fertilized oocyte) between Severe oligozoospermia (SO) and normspermic cases.
ClassRoom
Male factor infertility and assisted reproductive technologies: indications, minimum access criteria and outcomes
DOI:10.1007/s40618-022-02000-4 by Journal of Endocrinological Investigation in 2023
[256]
Severe male factor in in vitro fertilization: definition, prevalence, and treatment. An update
DOI:10.4103/aja.aja_53_21 by Asian Journal of Andrology in 2022
[255]
TextBook
Recurrent pregnancy loss: a male crucial factor - systematic review and meta-analysis.
DOI:10.1111/andr.13540 by Andrology. in 2023
[551]
Recent Publications
The clinical impact of oligozoospermia in oocyte donation ICSI cycles using preimplantation genetic test for aneuploidy
DOI:10.1093/humrep/deaf080 by Human Reproduction in 2025
[2715]
The impact of severe oligozoospermia on morphokinetic embryo development in low-prognosis patients according to the Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number criteria: an analysis of 10,366 injected oocytes
DOI:10.1016/j.xfss.2024.06.001 by F&S Science in 2024
[1684]
Clinical predictors of successful outcomes for couples with nonobstructive azoospermic male partners undergoing micro-TESE
DOI:10.4103/aja202436 by Asian Journal of Andrology in 2024
